1. Home
  2. COUR vs NEO Comparison

COUR vs NEO Comparison

Compare COUR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$5.27

Market Cap

932.9M

Sector

Technology

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.77

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COUR
NEO
Founded
2012
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
932.9M
1.0B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
COUR
NEO
Price
$5.27
$8.77
Analyst Decision
Buy
Strong Buy
Analyst Count
15
8
Target Price
$10.53
$13.38
AVG Volume (30 Days)
6.5M
2.1M
Earning Date
04-23-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
39.22
N/A
EPS
N/A
N/A
Revenue
$757,500,000.00
N/A
Revenue This Year
$9.43
$10.63
Revenue Next Year
$6.40
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
9.04
N/A
52 Week Low
$5.00
$4.72
52 Week High
$13.56
$13.74

Technical Indicators

Market Signals
Indicator
COUR
NEO
Relative Strength Index (RSI) 42.81 54.27
Support Level $5.11 $8.68
Resistance Level $6.41 $8.84
Average True Range (ATR) 0.31 0.43
MACD -0.06 -0.04
Stochastic Oscillator 16.27 41.77

Price Performance

Historical Comparison
COUR
NEO

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: